Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death

Cited by (1,010)

Items 801–900 of 1,010

1. Simple sugar intake and cancer incidence, cancer mortality and all-cause mortality: A cohort study from the PREDIMED trial
   Juan Carlos Laguna, Marta Alegret, Montserrat Cofán, Ana Sánchez‐Tainta, Andrés Díaz‐López, Miguel Ángel Martínez‐González, José Vicente Sorlí, Jordi Salas‐Salvadó, Montserrat Fitó, Ángel M. Alonso‐Gómez et al. · 2021 · Clinical Nutrition
2. Associations of HbA1c and educational level with risk of cardiovascular events in 32 871 drug‐treated patients with Type 2 diabetes: a cohort study in primary care
   Carl Johan Östgren, Johan Sundström, Bodil Svennblad, Leif Lohm, Peter M. Nilsson, G. Johansson · 2013 · Diabetic Medicine
3. Prediction model for type 2 diabetes mellitus and its association with mortality using machine learning in three independent cohorts from South Korea, Japan, and the UK: a model development and validation study
   Hayeon Lee, Seung Ha Hwang, Seoyoung Park, Yunjeong Choi, Sooji Lee, Jaeyu Park, Yejun Son, Hyeon Jin Kim, Soeun Kim, Jiyeon Oh et al. · 2025 · EClinicalMedicine
4. Potentially important considerations in choosing specific statin treatments to reduce overall morbidity and mortality
   Soo Kyung Lim, Ichiro Sakuma, Michael J. Quon, Kwang Kon Koh · 2012 · International Journal of Cardiology
5. Impact of Glucose-Lowering Agents on the Risk of Cancer in Type 2 Diabetic Patients. The Barcelona Case-Control Study
   Rafael Simó, Oleguer Plana‐Ripoll, Diana Puente, Rosa Morros, Xavier Mundet, Luz María Vilca, Cristina Hernández, Inmaculada Fuentes, Adriana Procupet, Josep M. Tabernero et al. · 2013 · PLoS ONE
6. Prognostic significance of diabetes mellitus in locally advanced non-small cell lung cancer
   Hisao Imai, Kyoichi Kaira, Keita P. Mori, Akira Ono, Hiroaki Akamatsu, Shunichi Matsumoto, Tetsuhiko Taira, Hirotsugu Kenmotsu, Hideyuki Harada, Tateaki Naito et al. · 2015 · BMC Cancer
7. Risk of mortality and recurrent cardiovascular events in patients with acute coronary syndromes on high intensity statin treatment
   Julia Rockberg, L. Jørgensen, Benjamin Taylor, Patrik Sobocki, G. Johansson · 2017 · Preventive Medicine Reports
8. Prevalence of obesity and diabetes in Spanish adults 1987–2012
   Francisco Javier Basterra-Gortari, Maira Bes‐Rastrollo, Miguel Ruiz‐Canela, Alfredo Gea, Miguel Ángel Martínez‐González · 2017 · Medicina Clínica (English Edition)
9. ‘Just like a normal pain’, what do people with diabetes mellitus experience when having a myocardial infarction: a qualitative study recruited from UK hospitals
   Nikita Berman, Melvyn Mark Jones, Daan A De Coster · 2017 · BMJ Open
10. Impact Of Hypertension versus Diabetes on Cardiovascular and All-cause Mortality in Iranian Older Adults: Results of 14 Years of Follow-up
    Neda Zafari, Samaneh Asgari, Mojtaba Lotfaliany, Amirreza Hadaegh, Fereidoun Azizi, Farzad Hadaegh · 2017 · Scientific Reports
11. Long-acting insulin analogs and cancer
    Laura Sciacca, Veronica Vella, Lucia Frittitta, Andrea Tumminia, Livia Manzella, Sebastiano Squatrito, Antonino Belfiore, Riccardo Vigneri · 2018 · Nutrition Metabolism and Cardiovascular Diseases
12. Impact of weight reduction on insulin resistance, adhesive molecules and adipokines dysregulation among obese type 2 diabetic patients
    Shehab Mahmoud Abd El-Kader, Osama H. Al-Jiffri · 2018 · African Health Sciences
13. Comorbidity assessment for mortality risk stratification in elderly patients with acute coronary syndrome
    Juan Manuel Sanchís, Meritxell Soler, Julio E. Núñez, Vicente Ruíz, Clara Bonanad, Francesç Formiga, Ernesto Valero, Manuel Martínez‐Sellés, Francisco R. Marín, María-Arántzazu Ruescas-Nicolau et al. · 2019 · European Journal of Internal Medicine
14. Association of pancreatic fat content with type II diabetes mellitus
    Collin J. Nadarajah, Ghaneh Fananapazir, Enming Cui, Judy Wawira Gichoya, Nilasha Thayalan, Michael Asare-Sawiri, Christine O. Menias, Kumaresan Sandrasegaran · 2019 · Clinical Radiology
15. A Dipeptidyl Peptidase-4 Inhibitor Inhibits Foam Cell Formation of Macrophages in Type 1 Diabetes via Suppression of CD36 and ACAT-1 Expression
    Michishige Terasaki, Hironori Yashima, Yusaku Mori, Tomomi Saito, Takanori Matsui, Munenori Hiromura, Hideki Kushima, Naoya Osaka, Makoto Ohara, Tomoyasu Fukui et al. · 2020 · International Journal of Molecular Sciences
16. Coronavirus infection (SARS-CoV-2) in obesity and diabetes comorbidities: is heat shock response determinant for the disease complications?
    Maurício da Silva Krause, Fernando Gerchman, Rogério Friedman · 2020 · Diabetology & Metabolic Syndrome
17. Causal Evaluation of Laboratory Markers in Type 2 Diabetes on Cancer and Vascular Diseases Using Various Mendelian Randomization Tools
    Heejin Jin, Sanghun Lee, Sungho Won · 2020 · Frontiers in Genetics
18. Increasing incidence of non-HBV- and non-HCV-related hepatocellular carcinoma: single-institution 20-year study
    Yuko Nagaoki, Hideyuki Hyogo, Yuwa Ando, Yumi Kosaka, Shinsuke Uchikawa, Yuno Nishida, Yuji Teraoka, Kei Morio, Hatsue Fujino, Atsushi Ono et al. · 2021 · BMC Gastroenterology
19. The molecular signature of impaired diabetic wound healing identifies serpinB3 as a healing biomarker
    Gian Paolo Fadini, Mattia Albiero, Renato Millioni, Nicol Poncina, Mauro Rigato, Rachele Scotton, Federico Boscari, Enrico Brocco, Giorgio Arrigoni, Gianmarco Villano et al. · 2014 · Diabetologia
20. Diabetes mellitus as a risk factor for gastrointestinal cancers among postmenopausal women
    Juhua Luo, Rowan T. Chlebowski, Simin Liu, Katherine A. McGlynn, Niyati Parekh, Donna L. White, Karen L. Margolis · 2012 · Cancer Causes & Control
21. Association between the TCF7L2 rs12255372 (G/T) gene polymorphism and type 2 diabetes mellitus in a Cameroonian population: a pilot study
    Dieudonne Nanfa, Eugène Sobngwi, Barbara Atogho‐Tiedeu, Jean Jacques Noubiap, Olivier Sontsa Donfack, E.P. Mofo Mato, Magellan Guewo‐Fokeng, Aurelie Nguimmo-Metsadjio, Elvis Ndonwi Ngwa, P. Fosso Pokam et al. · 2015 · Clinical and Translational Medicine
22. Type 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: an imaging study with positron emission tomography tracer 18F-fluoromethylcholine
    Sanna Hellberg, Johanna M. U. Silvola, Max Kiugel, Heidi Liljenbäck, Olli Metsälä, Tapio Viljanen, Jari Metso, Matti Jauhiainen, Pekka J. Saukko, Pirjo Nuutila et al. · 2016 · Cardiovascular Diabetology
23. The Placement of DPP-4 Inhibitors in Clinical Practice Recommendations for the Treatment of Types 2 Diabetes
    Jaime A. Davidson · 2013 · Endocrine Practice
24. Subclinical hyperthyroidism in patients with type 2 diabetes
    Juan José Díez, Pedro Iglesias · 2012 · Endocrine
25. Nonalcoholic Fatty Liver Disease Increases the Risk of Hepatocellular Carcinoma in Patients With Alcohol-Associated Cirrhosis Awaiting Liver Transplants
    Raluca Pais, Pascal Lebray, Géraldine Rousseau, Frédéric Charlotte, Ghizlaine Esselma, Éric Savier, Dominique Thabut, Marika Rudler, Daniel Eyraud, Corinne Vézinet et al. · 2014 · Clinical Gastroenterology and Hepatology
26. Effect of Tocotrienols enriched canola oil on glycemic control and oxidative status in patients with type 2 diabetes mellitus: A randomized double-blind placebo-controlled clinical trial
    Mohammadreza Vafa, Neda Haghighat, Nazanin Moslehi, Shahriar Eghtesadi, Iraj Heydari · 2015 · Journal of Research in Medical Sciences
27. The role of genetic variants in CYP2C8, LPIN1, PPARGC1A and PPARγ on the trough steady-state plasma concentrations of rosiglitazone and on glycosylated haemoglobin A1c in type 2 diabetes
    Tore Bjerregaard Stage, Mette Marie Hougaard Christensen, Søren Feddersen, Henning Beck‐Nielsen, Kim Brøsen · 2013 · Pharmacogenetics and Genomics
28. Economic aspects in the management of diabetes in Italy
    Andrea Marcellusi, R Viti, Paolo Sciattella, Gianluca Aimaretti, Salvatore De Cosmo, Vincenzo Provenzano, Giancarlo Tonolo, Francesco Saverio Mennini · 2016 · BMJ Open Diabetes Research & Care
29. Age-specific impact of diabetes mellitus on the risk of cardiovascular mortality: An overview from the evidence for Cardiovascular Prevention from Observational Cohorts in the Japan Research Group (EPOCH-JAPAN)
    Yoichiro Hirakawa, Toshiharu Ninomiya, Yutaka Kiyohara, Yoshitaka Murakami, Shigeyuki Saitoh, Hideaki Nakagawa, Akira Okayama, Akiko Tamakoshi, Kiyomi Sakata, Katsuyuki Miura et al. · 2017 · Journal of Epidemiology
30. Insulin prices, availability and affordability: a cross-sectional survey of pharmacies in Hubei Province, China
    Chenxi Liu, Xinping Zhang, Chaojie Liu, Margaret A Ewen, Zinan Zhang, Guoqin Liu · 2017 · BMC Health Services Research
31. BMI and Mortality in Patients With New-Onset Type 2 Diabetes: A Comparison With Age- and Sex-Matched Control Subjects From the General Population
    Jon Edqvist, Araz Rawshani, Martin Adiels, Lena M Bjorck, Marcus Lind, Ann‐Marie Svensson, Sofia Gudbjörnsdottir, Naveed A. Sattar, Annika Rosengren · 2018 · Diabetes Care
32. Progress in defining the genetic contribution to type 2 diabetes susceptibility
    Andrew P. Morris · 2018 · Current Opinion in Genetics & Development
33. Sex-specific associations between adolescent categories of BMI with cardiovascular and non-cardiovascular mortality in midlife
    Ariel Furer, Arnon B. Afek, Omri Orr, Liron Gershovitz, Moran Landau Rabbi, Estela Derazne, Orit Pinhas‐Hamiel, Noam Fink, Adi Leiba, Amir Tirosh et al. · 2018 · Cardiovascular Diabetology
34. Cardiovascular disease in diabetes type 2: current concepts
    Annika Rosengren · 2018 · Journal of Internal Medicine
35. Glucose Control, Sulfonylureas, and Insulin Treatment in Elderly People With Type 2 Diabetes and Risk of Severe Hypoglycemia and Death: An Observational Study
    Suping Ling, Francesco Zaccardi, Claire Lawson, Samuel Seidu, Melanie Jane Davies, Kamlesh Khunti · 2021 · Diabetes Care
36. Elevated glucose increases genomic instability by inhibiting nucleotide excision repair
    Alexandra K. Ciminera, Sarah C. Shuck, John S. Termini · 2021 · Life Science Alliance
37. Trends in Diabetes Mortality in Urban and Rural China, 1987–2019: A Joinpoint Regression Analysis
    Binbin Su, Yiran Wang, Yanhui Dong, Gang Hu, Yike Xu, Xiaobo Peng, Qianyun Wang, Xiaoying Zheng · 2022 · Frontiers in Endocrinology
38. Diabetes prevalence and risk factors of early-onset adult diabetes: results from the Indonesian family life survey
    Justine Tanoey, Heiko Becher · 2021 · Global Health Action
39. Screening for Liver Fibrosis in the General Population: Where Do We Stand in 2022?
    Clémence M. Canivet, Jérôme Boursier · 2022 · Diagnostics
40. Cardiovascular risk in rheumatoid arthritis and diabetes: how does it compare and when does it start?
    Michael Twahier Nurmohamed, George D. Kitas · 2011 · Annals of the Rheumatic Diseases
41. Diagnosed diabetes and premature death among middle-aged Japanese: results from a large-scale population-based cohort study in Japan (JPHC study)
    Masayuki Kato, Mitsuhiko Noda, Tetsuya Mizoue, Atsushi Goto, Yoshihiko Takahashi, Yumi Matsushita, Akiko Nanri, Hiroyasu Iso, Manami Inoue, Norie Sawada et al. · 2015 · BMJ Open
42. On the non-linear association between serum uric acid levels and all-cause mortality rate in patients with type 2 diabetes mellitus
    Olga Lamacchia, Andrea Fontana, Antonio Pacilli, Massimiliano Copetti, Stefania Fariello, Monia Garofolo, Giuseppe Penno, Vincenzo Trischitta, Salvatore De Cosmo, Mauro Cignarelli · 2017 · Atherosclerosis
43. Physical activity in patients with COPD: the impact of comorbidities
    Leandro Cruz Mantoani, Silvina Dell’Era, William MacNee, Roberto Rabinovich · 2017 · Expert Review of Respiratory Medicine
44. Current type 2 diabetes guidelines: Individualized treatment and how to make the most of metformin
    Juliana C.N. Chan, Aimin Yang, Natural Hoi Sing Chu, Elaine Chow · 2024 · Diabetes Obesity and Metabolism
45. The excess mortality related to cardiovascular diseases and cancer among adults pharmacologically treated for diabetes—the 2001–2006 ENTRED cohort
    Isabelle Romon, Grégoire Rey, Laurence Mandereau-Bruno, Alain Weill, Éric Jougla, É. Eschwège, D. Simon, Céline Druet, Anne Fagot‐Campagna · 2014 · Diabetic Medicine
46. Extra-pancreatic effects of incretin-based therapies
    Baptist Gallwitz · 2014 · Endocrine
47. A New Tool to Detect Kidney Disease in Chinese Type 2 Diabetes Patients: Comparison of EZSCAN with Standard Screening Methods
    Risa Ozaki, Kitty Kit-Ting Cheung, Enoch Wu, Alice P.S. Kong, Xilin Yang, Eric S. H. Lau, Philippe Brunswick, Jean‐Henri Calvet, J.P. Deslypère, Juliana C.N. Chan · 2011 · Diabetes Technology & Therapeutics
48. Primary and secondary prevention of cardiovascular disease in diabetes with aspirin
    Oliver Schnell, Michael Erbach, Michael Hummel · 2012 · Diabetes and Vascular Disease Research
49. Detecting people at high risk of type 2 diabetes- How do we find them and who should be treated?
    Alice P.S. Kong, Andrea O. Y. Luk, Juliana C.N. Chan · 2016 · Best Practice & Research Clinical Endocrinology & Metabolism
50. Association of Hypertension and Diabetes with Ischemic Heart Disease and Stroke Mortality in India: The Million Death Study
    Calvin Ke, Rajeev Gupta, Baiju R. Shah, Thérèse A. Stukel, Denis Xavier, Prabhat Jha · 2021 · Global Heart
51. Protocol for the Metformin Aneurysm Trial (MAT): a placebo-controlled randomised trial testing whether metformin reduces the risk of serious complications of abdominal aortic aneurysm
    Jonathan Golledge, Clare Gabrielle Arnott, Joseph Vaughan Moxon, Helen Monaghan, Richard Norman, Dylan Morris, Qiang Li, Gregory T. Jones, Justin Roake, Matthew J. Bown et al. · 2021 · Trials
52. Time course of serum uric acid accumulation and the risk of diabetes mellitus
    Xue Tian, Anxin Wang, Yingting Zuo, Shuohua Chen, Licheng Zhang, Yuhan Zhao, Lulu Liu, Shouling Wu, Yanxia Luo, Jingli Gao · 2022 · Nutrition and Diabetes
53. Impaired Hematopoietic Stem/Progenitor Cell Traffic and Multi-organ Damage in Diabetes
    G. Fadini, M. Albiero · 2022 · Stem Cells
54. Contribution of the TCF7L2 rs7903146 (C/T) gene polymorphism to the susceptibility to type 2 diabetes mellitus in Cameroon
    Magellan Guewo‐Fokeng, Eugène Sobngwi, Barbara Atogho‐Tiedeu, Olivier Sontsa Donfack, Jean Jacques Noubiap, Elvis Ndonwi Ngwa, E.P. Mofo Mato, P. Fosso Pokam, Eric Noel Djahmeni, Rosine Djokam-Dadjeu et al. · 2015 · Journal of Diabetes & Metabolic Disorders
55. Validity of type 2 diabetes diagnosis in a population-based electronic health record database
    Conchi Moreno‐Iribas, Carmen Sayón-Orea, Josu Delfrade, Eva Ardanáz, Javier Gorricho, Rosana Burgui, Marian Nuín, Marcela Guevara · 2017 · BMC Medical Informatics and Decision Making
56. Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy
    Milana A. Bergamino, Antonio Rullan, Maria Saigí, Inmaculada Peiró, Eduard Montanya, Ramón Palmero, José Carlos Ruffinelli, Arturo Navarro-Martín, Maria Dolores Arnaiz, Isabel Brao et al. · 2019 · BMC Cancer
57. High-MUFA Diets Reduce Fasting Glucose in Patients with Type 2 Diabetes
    Lukas Schwingshackl, Barbara Strasser · 2012 · Annals of Nutrition and Metabolism
58. Within-trial cost and 1-year cost-effectiveness of the DiRECT/Counterweight-plus weight-management programme to achieve remission of type 2 diabetes
    Xin, Yiqiao, Davies, Andrew, McCombie, Louise, Briggs, Andrew, Messow, C-Martina, Grieve, Eleanor, Leslie, Wilma S, Taylor, Roy, Lean, Michael E J · 2019 · The Lancet Diabetes & Endocrinology
59. Is HbA1c a valid surrogate for macrovascular and microvascular complications in type 2 diabetes?
    Théodora Bejan‐Angoulvant, Catherine Cornu, P. Archambault, Benoit Valentin Tudrej, P. Audier, Y. Brabant, François Gueyffier, Rémy Boussageon · 2015 · Diabetes & Metabolism
60. Traditional Risk Factors Alone Could Not Explain the Excess Mortality in Patients With Diabetes
    Enrique Regidor, Josep Franch‐Nadal, Mateu Seguí, Rosario Serrano, Fernando Rodríguez‐Artalejo, Sara Artola · 2012 · Diabetes Care
61. Predictive models for all-cause and cardiovascular mortality in type 2 diabetic inpatients. A cohort study
    Dolores Ramírez-Prado, Antonio Palazón‐Bru, D. M. Folgado-de-la Rosa, María Ángeles Carbonell‐Torregrosa, Ana María Martínez‐Díaz, Vicente Francisco Gil-Guillén · 2014 · International Journal of Clinical Practice
62. Is diabetes mellitus a negative prognostic factor for the treatment of advanced non-small-cell lung cancer?
    Ali̇ İnal, Kaplan Ma, Mehmet Küçüköner, Zuhat Urakçı, Faruk Kılınç, Abdurrahman Işıkdoğan · 2013 · Revista Portuguesa de Pneumologia
63. Serum glucose and hemoglobin A1C levels at cancer diagnosis and disease outcome
    Ben Boursi, Bruce J. Giantonio, James D. Lewis, Kevin Haynes, Ronac Mamtani, Yu‐Xiao Yang · 2016 · European Journal of Cancer
64. Association of High Homocysteine Levels With the Risk Stratification in Hypertensive Patients at Risk of Stroke
    Hui Pang, Bing Han, Qiang Fu, Zhenkun Zong · 2016 · Clinical Therapeutics
65. Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial
    Atsushi Tanaka, Michio Shimabukuro, Yosuke Okada, Isao Taguchi, Minako Yamaoka‐Tojo, Hirofumi Tomiyama, Hiroki Teragawa, Seigo Sugiyama, Hisako Yoshida, Yasunori Sato et al. · 2017 · Cardiovascular Diabetology
66. A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus
    Danielle Crawley, Florence Chamberlain, Hans Garmo, Sarah Maria Rudman, Björn Zethelius, Lars Holmberg, Jan Adolfsson, Pär E. Stattin, Paul Carroll, Mieke Van Hemelrijck · 2018 · ecancermedicalscience
67. Cardiovascular and mortality events in type 2 diabetes cardiovascular outcomes trials: a systematic review with trend analysis
    Lorenzo Maria Vetrone, Francesco Zaccardi, David R. Webb, Samuel Seidu, Nitin Narayan Gholap, Dario Pitocco, Melanie Jane Davies, Kamlesh Khunti · 2018 · Acta Diabetologica
68. Potent Oral Hypoglycemic Agents for Microvascular Complication: Sodium-Glucose Cotransporter 2 Inhibitors for Diabetic Retinopathy
    Eun Hyung Cho, Se-Jun Park, Seong‐Wook Han, Ji Hun Song, Kihwang Lee, Yoo-Ri Chung · 2018 · Journal of Diabetes Research
69. Towards adequate prediction of prediabetes using spatiotemporal ECG and EEG feature analysis and weight-based multi-model approach
    Tobore Igbe, Abhishek Kandwal, Jingzhen Li, Yan Yan, Olatunji Mumini Omisore, Efetobore Enitan, Sinan Li, Liu Yuhang, Lei Wang, Zedong Nie · 2020 · Knowledge-Based Systems
70. Plasma Imidazole Propionate Is Positively Correlated with Blood Pressure in Overweight and Obese Humans
    Jamie van Son, Mireille J. M. Serlie, Marcus Ståhlman, Fredrik Bäckhed, Max Nieuwdorp, Judith Aron‐Wisnewsky · 2021 · Nutrients
71. Ethnic disparities in medication adherence? A systematic review examining the association between ethnicity and antidiabetic medication adherence
    Rayah Asiri, Adam Todd, Anna Robinson, Andy Husband · 2023 · PLoS ONE
72. The meaning of insulin to Hispanic immigrants with type 2 diabetes and their families.
    Jie Hu, Karen A. Amirehsani, D. Wallace, S. Letvak · 2012 · The diabetes educator
73. How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCT
    Shigeo Fuji, Alicia Rovó, K Ohashi, M Griffith, Hermann Einsele, Markus Kapp, Mohamad Mohty, Navneet S. Majhail, Brian G. Engelhardt, André Tichelli et al. · 2016 · Bone Marrow Transplantation
74. Niclosamide reduces glucagon sensitivity via hepatic PKA inhibition in obese mice: Implications for glucose metabolism improvements in type 2 diabetes
    Md. Kamrul Hasan Chowdhury, Nigel A. Turner, Nicholas L. Bentley, Abhirup Das, Lindsay E. Wu, Dulama Richani, Sonia Bustamante, Robert Bruce Gilchrist, Margaret J. Morris, Peter Robin Shepherd et al. · 2017 · Scientific Reports
75. Glycaemia control and the risk of hospitalisation for infection in patients with type 2 diabetes: Hong Kong Diabetes Registry
    Andrea O. Y. Luk, Eric S. H. Lau, Kitty Kit-Ting Cheung, Alice P.S. Kong, Ronald C.W., Risa Ozaki, Francis C. C. Chow, Wing‐Yee So, Juliana C.N. Chan · 2017 · Diabetes/Metabolism Research and Reviews
76. When metformin is not enough: Pros and cons of SGLT2 and DPP‐4 inhibitors as a second line therapy
    Angelo Avogaro, Elías Delgado, Ildiko Lingvay · 2018 · Diabetes/Metabolism Research and Reviews
77. Therapeutic potentials of Nigella sativa preparations and its constituents in the management of diabetes and its complications in experimental animals and patients with diabetes mellitus: A systematic review
    Mohammad Reza Mahmoodi, Mehdi Mohammadizadeh · 2020 · Complementary Therapies in Medicine
78. Non-HDL cholesterol goal attainment and its relationship with triglyceride concentrations among diabetic subjects with cardiovascular disease: a nationwide survey of 2674 individuals in Hungary
    Mark, Laszlo, Vallejo-Vaz, Antonio J., Reiber, Istvan, Paragh, György, Kondapally Seshasai, Sreenivasa Rao, Ray, Kausik K. · 2015 · Atherosclerosis
79. Liraglutide and cardiovascular outcomes in a real world type 2 diabetes cohort
    Marco Mirani, Giuseppe Favacchio, Eliseo Serone, Giuseppe Lucisano, Maria Chiara Rossi, Cesare Berra · 2018 · Pharmacological Research
80. The influence of comorbid chronic diseases and physical activity on quality of life in lung cancer survivors
    Jiwei Wang, Xiong-Huan Gong, Ning Ding, Xuefen Chen, Li Sun, Zheng Tang, Dong-Hui Yu, Zhengping Yuan, Xiangdong Wang, Jinming Yu · 2014 · Supportive Care in Cancer
81. Risk factors for cardiovascular disease and mortality events in adults with type 2 diabetes — a 10‐year follow‐up: Tehran Lipid and Glucose Study
    Sheila Afsharian, Samaneh Akbarpour, Hengameh Abdi, Farhad Haj Sheikholeslami, Ali Siamak Habibi Moeini, Davood Khalili, Amir Abbas Momenan, Fereidoun Azizi, Farzad Hadaegh · 2016 · Diabetes/Metabolism Research and Reviews
82. Risk Assessment in Patients With Diabetes With the TIMI Risk Score for Atherothrombotic Disease
    Brian A. Bergmark, Deepak L. Bhatt, Eugene Braunwald, David A. Morrow, Philippe Gabríel Steg, Yared Gurmu, Avivit Cahn, Ofri Mosenzon, Itamar Raz, Erin Ann Bohula et al. · 2017 · Diabetes Care
83. TRPV1 neurons regulate β-cell function in a sex-dependent manner
    Joey Bou Karam, Wei-Kang Cai, Rowaida Mohamed, Tianwen Huang, L. Meng, Erica P. Homan, E. Dirice, C. R. Kahn, A. El Ouaamari · 2018 · Molecular Metabolism
84. Low fasting glucose and future risks of major adverse outcomes in people without baseline diabetes or cardiovascular disease: a systematic review and meta-analysis
    Hung‐Wei Liao, Jeffrey L. Saver, Hsin‐Chieh Yeh, Chi-Hsin Sally Chen, Yi‐Ling Wu, Meng Lee, Bruce I Ovbiagele · 2019 · BMJ Open
85. Pharmacological management of vascular endothelial dysfunction in diabetes: TCM and western medicine compared based on biomarkers and biochemical parameters
    Patrick Kwabena Oduro, Jingmei Fang, Lu Niu, Yuhong Li, Lin Li, Xin Zhao, Qilong Wang · 2020 · Pharmacological Research
86. Effect of diabetes mellitus and glycemic control on the prognosis of non-muscle invasive bladder cancer: a retrospective study
    Wei‐Lun Huang, Kuo‐How Huang, Chao‐Yuan Huang, Yeong‐Shiau Pu, Hong‐Chiang Chang, Po‐Ming Chow · 2020 · BMC Urology
87. Atherogenic Dyslipidemia on Admission Is Associated With Poorer Outcome in People With and Without Diabetes Hospitalized for COVID-19
    Alfonso Bellia, Aikaterini Andreadi, Luca Giudice, Sofia De Taddeo, Alessio Maiorino, Ilenia D’Ippolito, Federica Maria Giorgino, Valeria Ruotolo, Maria Romano, Andrea Magrini et al. · 2021 · Diabetes Care
88. The Role of Bone-Derived Hormones in Glucose Metabolism, Diabetic Kidney Disease, and Cardiovascular Disorders
    Yuichi Takashi, Daiji Kawanami · 2022 · International Journal of Molecular Sciences
89. Heterogeneous treatment effects of intensive glycemic control on major adverse cardiovascular events in the ACCORD and VADT trials: a machine-learning analysis
    Justin A. Edward, Kevin Josey, Gideon Bahn, Liron Caplan, Jane E.B. Reusch, Peter D. Reaven, Debashis Ghosh, Sridharan Raghavan · 2022 · Cardiovascular Diabetology
90. Association between sarcopenia and prediabetes among non-elderly US adults
    Jiahui Xu, Xu Han, Q. Chen, M. Cai, Jing Tian, ZiJia Yan, Qiuyue Guo, Jiahui Xu, Hao Lü · 2023 · Journal of Endocrinological Investigation
91. Association of Hyperglycemia on Admission and During Hospitalization with Mortality in Diabetic Patients Admitted for Pneumonia
    Yu Hirata, Hiromi Tomioka, Reina Sekiya, Shyuji Yamashita, Toshihiko Kaneda, Yoko Kida, Chihiro Nishio, Masahiro Kaneko, Hiroshi Fujii, Takehiro Nakamura · 2013 · Internal Medicine
92. Metformin and Not Diabetes Influences the Survival of Resected Early Stage NSCLC Patients
    Samjot Singh Dhillon · 2014 · Journal of Cancer Science & Therapy
93. Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis
    Wahyu Wulaningsih, Mariam Vahdaninia, M. Rowley, Lars Holmberg, Hans Garmo, Håkan Malmström, Mats P. Lambe, Niklas Hammar, Göran Walldius, Ingmar Jungner et al. · 2015 · BMC Cancer
94. Circulating Concentrations of Redox Biomarkers Do Not Improve the Prediction of Adverse Cardiovascular Events in Patients With Type 2 Diabetes Mellitus
    Maxime Cournot, Elena Burillo, Pierre‐Jean Saulnier, Cynthia Planesse, Elise Gand, Michaela Beatrice Rehman, Stéphanie Ragot, Philippe Rondeau, Aurélie Catan, Marie‐Paule Gonthier et al. · 2018 · Journal of the American Heart Association
95. The effects of glucagon-like peptide-1 receptor agonists on adipose tissues in patients with type 2 diabetes: A meta-analysis of randomised controlled trials
    Liu, Fupeng, Yang, Qing, Zhang, Hongli, Zhang, Yanhong, Yang, Guangzhi, Ban, Bo, Li, Yanying, Zhang, Mei · 2022 · PLOS ONE
96. Mortality in patients with diabetes mellitus and Addison's disease: a nationwide, matched, observational cohort study
    Chantzichristos, Dimitrios, Persson, Anders, Eliasson, Björn, Miftaraj, Mervete, Franzén, Stefan, Bergthorsdottir, Ragnhildur, Gudbjörnsdottir, Soffia, Svensson, Ann-Marie, Johannsson, Gudmundur · 2017 · European Journal of Endocrinology
97. The effects of passive stretching on the blood glucose levels of patients with type 2 diabetes
    Navid Taheri, Hosein Kouhzad Mohammadi, Gholamreza Jafarian Ardakani, Mojtaba Heshmatipour · 2018 · Journal of Bodywork and Movement Therapies
98. 2020 Consensus of Taiwan Society of Cardiology on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases
    Chern‐En Chiang, Kwo-Chang Ueng, Ting‐Hsing Chao, Tsung‐Hsien Lin, Yih-Jer Wu, Kang-Ling Wang, Shih‐Hsien Sung, Hung‐I Yeh, Yi‐Heng Li, Ping‐Yen Liu et al. · 2020 · Journal of the Chinese Medical Association
99. Targeting endothelial cells with golden spice curcumin: A promising therapy for cardiometabolic multimorbidity
    Fei Tang, Dong Liu, Li Zhang, Li-Yue Xu, Jingnan Zhang, Xiaolan Zhao, Hui Ao, Cheng Yun Peng · 2023 · Pharmacological Research
100. Effectiveness of glucose-lowering medications on cardiovascular outcomes in patients with type 2 diabetes at moderate cardiovascular risk
     McCoy, Rozalina G., Herrin, Jeph, Swarna, Kavya Sindhu, Deng, Yihong, Kent, David M., Ross, Joseph S., Umpierrez, Guillermo E., Galindo, Rodolfo J., Crown, William H., Borah, Bijan J. et al. · 2024 · Nature Cardiovascular Research